Bionanotechnology II
Global Prospects
A wide-ranging global perspective of this rapidly evolving bionanotechnology sector, this book covers the biological processes and structures being used to develop technologies that can improve medicine and agriculture. Topics include: self-assembly, cell detection strategies, and medical diagnostics, labeling, and imaging, as well as development of antiviral therapeutics, drug delivery, tissue engineering, and theragnostic nanoparticles that can diagnose, treat, and monitor diseases. Discussing the formation of crucial one-dimensional nanostructures that can lead to advances such as development of novel nanowires and other devices, this book…
Mehr
CHF 225.00
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
V136:
Neuauflage/Nachdruck unbestimmt
Produktdetails
- ISBN: 978-1-4398-0463-6
- EAN: 9781439804636
- Produktnummer: 23273978
- Verlag: Taylor & Francis Inc
- Sprache: Englisch
- Erscheinungsjahr: 2011
- Seitenangabe: 584 S.
- Masse: H25.6 cm x B18.4 cm x D3.3 cm 1'148 g
- Abbildungen: 14-page color insert 28 figures to follow page 312; 30 Tables, black and white; 167 Illustrations, black and white
- Gewicht: 1148
- Sonstiges: Postgraduate, Research & Scholarly
Über den Autor
David E. Reisner is a well-known early pioneer and entrepreneur in the burgeoning field of nanotechnology. In 1996, he cofounded two nanotech companies in Connecticut: Inframat and U.S. Nanocorp. For nearly 15 years, he was CEO of both companies since founding. He was featured in Forbes in 2004 and was a Technology Pioneer at the World Economic Forum Annual Meeting in Davos. He has over 175 publications and is an inventor on 10 issued patents.
Bewertungen
Anmelden